B lymphocytes are resistant to death receptor 5-induced apoptosis
Open Access
- 1 April 2011
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 139 (1) , 21-31
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signallingBiochemical Journal, 2009
- Identification of an antiapoptotic protein complex at death receptorsCell Death & Differentiation, 2008
- Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAILNature Medicine, 2007
- Cleavage of p53-Vimentin Complex Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis of Rheumatoid Arthritis Synovial FibroblastsThe American Journal of Pathology, 2005
- Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL SensitivityMolecular and Cellular Biology, 2004
- Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cellsGynecologic Oncology, 2004
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death DomainImmunity, 1997
- Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center developmentSeminars in Immunology, 1996
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996